Memorial Sloan Kettering Cancer Center Annual Cancer Treatment-Related Adverse Events Symposium 2019
Overview
24 videos + 23 pdfs, size: 8.95 GB
Information:
Friday, October 25, 2019, 8:00 AM – Saturday, October 26, 2019, 2:00 PM EST, Rockefeller Research Laboratories, 430 East 67th Street, New York, NY
Systemic anticancer therapies (cytotoxic chemotherapies, targeted therapies, immunotherapies) have resulted in remarkable improvements in patient survival. Despite this remarkable success, the majority of patients will develop toxicities of various organ systems, which may impact overall health and activities of daily living, resulting in inconsistent antineoplastic therapy, all of which may affect clinical outcome. Therefore, prevention and management of untoward events is critical for the maintenance of quality of life and the optimization of anticancer therapies.
The target audience for this symposium includes MDs, PAs, NPs, RNs, Pharmacists, and other professionals treating cancer patients and their associated symptoms.
Symposium Highlights
- Therapy-related adverse events will affect the majority of cancer patients, resulting in increased cost, inconsistent dosing, and decreased quality of life.
- With increased survival and patients living longer on therapy, adverse events affecting quality of life and clinical outcome command attention.
- Lectures focused on immune-related adverse events will describe clinical presentation, diagnosis, and management strategies for the oncology healthcare provider.
- Up-to-date information will be presented on adverse event mechanisms and management from specialists in the most commonly affected organ systems.
- Practical strategies to maintain patients’ quality of life and dose intensity will be highlighted for the most frequently occurring events.
- Recognize the clinical presentation and impact on quality of life of treatment-related adverse events
- Understand mechanisms and interventions to prevent and treat adverse events
- Discuss procedures and clinical tools to assess treatment-related toxicities in cancer patients
List of Topics:
AdverseEvents2019Brochure.pdf
Cardiac Toxicities.mp4
Cardiac Toxicities.pdf
Hyperglycemia and Cushing Disease.mp4
Hyperglycemia and Cushing Disease.pdf
Hypersensitivity Reactions.mp4
Hypersensitivity Reactions.pdf
Immune Related Endocrine Toxicities.mp4
Immune-Related Adverse Events – Kidney.mp4
Immune-Related Adverse Events – Kidney.pdf
Immune-Related Cardiac Events.mp4
Immune-Related Cardiac Events.pdf
Immune-Related Dermatologic Toxicities.mp4
Immune-Related Dermatologic Toxicities.pdf
Immune-Related GI Adverse Events.mp4
Immune-Related GI Adverse Events.pdf
Immune-Related Neurologic Events.mp4
Immune-Related Neurologic Events.pdf
Immune-Related Pulmonary Events.mp4
Immune-Related Pulmonary Events.pdf
Immune-Related Rheumatic Disorders.mp4
Immune-Related Rheumatic Disorders.pdf
Integrative Medicine in Oncology.mp4
Integrative Medicine in Oncology.pdf
Menopausal Symptom Management in Breast Cancer Survivors.mp4
Menopausal Symptom Management in Breast Cancer Survivors.pdf
Misery Loves Company — AE Symptom Clusters.mp4
Misery Loves Company — AE Symptom Clusters.pdf
Mucositis and Stomatitis.mp4
Mucositis and Stomatitis.pdf
Nausea and Vomiting.mp4
Nausea and Vomiting.pdf
Ocular Toxicities.mp4
Ocular Toxicities.pdf
Panel Discussion I.mp4
Research on GI Toxicities, Past, Present and Future.mp4
Research on GI Toxicities, Past, Present and Future.pdf
Severe Immune-Related Adverse Events.mp4
Severe Immune-Related Adverse Events.pdf
Treatment-Related Psychiatric and Cognitive Disorders.mp4
Treatment-Related Psychiatric and Cognitive Disorders.pdf
VTE and Treatment-Related Coagulopathies.mp4
VTE and Treatment-Related Coagulopathies.pdf
Welcome and Introduction- Importance of Adverse Events.mp4
Welcome and Introduction- Importance of Adverse Events.pdf
Welcome and Introduction- Multidisciplinary AE Management.mp4
Welcome and Introduction- Multidisciplinary AE Management.pdf